Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 01, 2016
- Source ID
- 10.1016/j.bbmt.2016.02.013
Entities
People
- Brenda M. Sandmaier
- Daniel J Weisdorf
- Hai Lin Wang
- Hanna J Khoury
- Marcos de Lima
- Reinhold Munker
- Richard T. Maziarz
- Robert Peter Gale
- Ruta Brazauskas
- Wael Saber
Organizations
- ARIAD Pharmaceuticals
- Actinium Pharmaceuticals (United States)
- Amgen
- Blue Cross Blue Shield Association
- Celgene
- Elevance Health, Inc.
- Fred Hutchinson Cancer Center
- GSK
- Genzyme
- Health Research
- HistoGenetics (United States)
- Incyte
- Kiadis Pharma (Netherlands)
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Merck & Co.
- Milliman
- Miltenyi Biotec
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Onyx Pharmaceuticals
- Osiris Therapeutics
- Otsuka (United States)
- Roche (United States)
- Roswell Park Comprehensive Cancer Center
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- St. Baldrick's Foundation
- StemCyte
- Swedish Orphan Biovitrum
- Tarix Orphan (United States)
- Terumo BCT (United States)
- United States Department of Health and Human Services
- University of Minnesota
- University of Utah